Ya-Qiong He
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ya-Qiong He has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Peng Liu
Department of Radiology, Hunan Provincial People’s Hospital, First Affiliated Hospital of Hunan Normal University, Changsha, China
4 shared publications- Peng Liu
Department of Radiology, Hunan Provincial People’s Hospital and The First Affiliated Hospital of Hunan Normal University, Changsha, China
3 shared publications Ting Dai
Department of Radiology, Hunan Provincial People’s Hospital and the First Affiliated Hospital of Hunan Normal University , Changsha, Hunan 410005
3 shared publications- Ting Dai
Department of Radiology, The First Affiliated Hospital of Hunan Normal University (Hunan Provincial People's Hospital), Changsha, Hunan, People's Republic of China
3 shared publications Ying-Jie Peng
3 shared publicationsYing-Lan Tang
Department of Radiology, The First Affiliated Hospital of Hunan Normal University (Hunan Provincial People's Hospital), Changsha, Hunan, China
2 shared publications
Latest Publications
- Open Access
- 21 August 2026
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Nomogram model based on dual-energy CT quantitative parameters and radiomics for preoperative prediction of microvascular invasion in hepatocellular carcinoma
- 21 August 2026
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Open AccessNomogram model based on dual-energy CT quantitative parameters and radiomics for preoperative prediction of microvascular invasion in hepatocellular carcinoma
- 29 July 2026
- Published by Elsevier in Pediatric Neurology
- Vol. 183, 186-188
Brain Abscess as the Initial Manifestation of Hereditary Hemorrhagic Telangiectasia in a Child
- 29 July 2026
- Published by Elsevier in Pediatric Neurology
- Vol. 183, 186-188
Brain Abscess as the Initial Manifestation of Hereditary Hemorrhagic Telangiectasia in a Child
- Open Access
- 6 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-10
Development and validation of a CT-measured body composition radiomics model for prognostic assessment in resected pancreatic adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis due to high post-resection recurrence, yet current prognostic tools inadequately capture systemic tumor-host interactions. This study developed and validated a novel CT-based body composition radiomics model for predicting recurrence-free survival (RFS) in 191 PDAC patients undergoing curative resection. Using a temporal validation design (training cohort: 2019–2022, n = 142; validation cohort: 2016–2018, n = 49), we extracted 1,688 radiomics features from adipose and muscle tissues at the L3 vertebral level. Following a standardized feature selection protocol (variance filtering, correlation reduction, and Cox regression), we constructed fat- and muscle-specific radiomics scores, combining them into a unified risk stratification system. The combined model effectively identified high-risk patients with significantly reduced RFS (HR = 6.455, p < 0.001), achieving consistent performance across cohorts (C-index: 0.71 training, 0.69 validation). This approach quantifies metabolic alterations in body composition, providing a clinically actionable tool to guide personalized therapy decisions—including intensified neoadjuvant regimens for high-risk patients or standard surveillance for low-risk individuals.
- 6 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-10
Open AccessDevelopment and validation of a CT-measured body composition radiomics model for prognostic assessment in resected pancreatic adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis due to high post-resection recurrence, yet current prognostic tools inadequately capture systemic tumor-host interactions. This study developed and validated a novel CT-based body composition radiomics model for predicting recurrence-free survival (RFS) in 191 PDAC patients undergoing curative resection. Using a temporal validation design (training cohort: 2019–2022, n = 142; validation cohort: 2016–2018, n = 49), we extracted 1,688 radiomics features from adipose and muscle tissues at the L3 vertebral level. Following a standardized feature selection protocol (variance filtering, correlation reduction, and Cox regression), we constructed fat- and muscle-specific radiomics scores, combining them into a unified risk stratification system. The combined model effectively identified high-risk patients with significantly reduced RFS (HR = 6.455, p < 0.001), achieving consistent performance across cohorts (C-index: 0.71 training, 0.69 validation). This approach quantifies metabolic alterations in body composition, providing a clinically actionable tool to guide personalized therapy decisions—including intensified neoadjuvant regimens for high-risk patients or standard surveillance for low-risk individuals.
- 25 July 2025
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 98 (1174) , 1671-1676
Comparison of the different imaging time points in delayed dual-energy CT extracellular volume in assessing the staging of liver fibrosis
Objective: To stage liver fibrosis by using delayed dual-energy CT (DECT) and determine the optimal delay time for acquisition of delayed CT scans. Materials and methods: This prospective study included patients with chronic liver disease, who were scheduled to undergo multiphase abdominal DECT (including 3-min and 5-min delayed periods) and liver biopsies from January 2021 to December 2021. The iodine densities of the parenchyma and aorta were measured and extracellular volume (ECV) was calculated. Kendall rank correlation was employed to assess the relationship between the ECV and the fibrosis stage. Comparison of ECVs was made for different stages of liver fibrosis. In addition, the diagnostic performances of ECV for staging liver fibrosis were evaluated by using receiver operating characteristic (ROC) curve analysis, and area under the curve (AUC) was calculated. Results: A total of 90 participants were evaluated, and distributed as follows: 10 in S1, 29 in S2, 25 in S3, and 26 in S4. Both ECV of 3-min delayed (ECV3 min) and 5-min delayed (ECV5 min) showed a positive correlation with the stage of liver fibrosis (ECV3 min: τ = 0.478, P < .01, moderate correlation; ECV5 min: τ = 0.352, P < .01, weak correlation). In terms of diagnostic performances, ECV3 min showed significantly higher diagnostic accuracy than ECV5 min for significant liver fibrosis (S2–4) (AUC: 0.87 vs 0.79, P = .037), but no significant differences were observed for progressive fibrosis (S3–4) (AUC: 0.76 vs 0.71, P = .206) or cirrhosis (S4) (AUC: 0.75 vs 0.74, P = .774). Conclusions: DECT ECV may have some potential in noninvasively liver fibrosis staging, ECV3 min is not definitely inferior to ECV5 min. Advances in knowledge: A 3-min delay for the delayed-phase ECV assessment can guide clinical treatment decisions for patients and enhance the efficiency of scanning work, holding significant clinical value.
- 25 July 2025
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 98 (1174) , 1671-1676
Comparison of the different imaging time points in delayed dual-energy CT extracellular volume in assessing the staging of liver fibrosis
Objective: To stage liver fibrosis by using delayed dual-energy CT (DECT) and determine the optimal delay time for acquisition of delayed CT scans. Materials and methods: This prospective study included patients with chronic liver disease, who were scheduled to undergo multiphase abdominal DECT (including 3-min and 5-min delayed periods) and liver biopsies from January 2021 to December 2021. The iodine densities of the parenchyma and aorta were measured and extracellular volume (ECV) was calculated. Kendall rank correlation was employed to assess the relationship between the ECV and the fibrosis stage. Comparison of ECVs was made for different stages of liver fibrosis. In addition, the diagnostic performances of ECV for staging liver fibrosis were evaluated by using receiver operating characteristic (ROC) curve analysis, and area under the curve (AUC) was calculated. Results: A total of 90 participants were evaluated, and distributed as follows: 10 in S1, 29 in S2, 25 in S3, and 26 in S4. Both ECV of 3-min delayed (ECV3 min) and 5-min delayed (ECV5 min) showed a positive correlation with the stage of liver fibrosis (ECV3 min: τ = 0.478, P < .01, moderate correlation; ECV5 min: τ = 0.352, P < .01, weak correlation). In terms of diagnostic performances, ECV3 min showed significantly higher diagnostic accuracy than ECV5 min for significant liver fibrosis (S2–4) (AUC: 0.87 vs 0.79, P = .037), but no significant differences were observed for progressive fibrosis (S3–4) (AUC: 0.76 vs 0.71, P = .206) or cirrhosis (S4) (AUC: 0.75 vs 0.74, P = .774). Conclusions: DECT ECV may have some potential in noninvasively liver fibrosis staging, ECV3 min is not definitely inferior to ECV5 min. Advances in knowledge: A 3-min delay for the delayed-phase ECV assessment can guide clinical treatment decisions for patients and enhance the efficiency of scanning work, holding significant clinical value.
- Open Access
- 1 June 2025
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 15 (6) , 5101-5113
Value of dual-energy computed tomography quantitative parameters in differentiating neoplastic from bland portal vein thrombosis
Background: Portal vein thrombosis (PVT) is a common clinical pathological state involving distinct pathophysiological processes. Accurate discrimination of PVT nature is of utmost importance for guiding treatment strategies, but histopathology has limitations and imaging lacks quantitative indices. This study aimed to evaluate the feasibility and diagnostic value of quantitative parameters from dual-energy computed tomography (DECT), an advanced technique that allows for such quantitative evaluation, in distinguishing neoplastic from bland PVT. Methods: Computed tomography (CT) images of 173 patients with PVT (bland group, n=74; neoplastic group, n=99) were retrospectively analyzed. Portal venous phase iodine-based decomposition images were reconstructed to contrast iodine indices among groups, including thrombus iodine concentration (IC), normalized iodine concentration in the aorta (NIC-A), normalized iodine concentration in the portal vein (NIC-V), electron density (Rho), effective atomic number (Z), dual-energy index (DEI), and spectral slope (K). Diagnostic performance was evaluated using the area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and accuracy. Univariate and multivariate analyses selected DECT parameters and created a nomogram for prediction. Results: (I) The values of IC, NIC-A, NIC-V, Rho, Z, DEI, and K were significantly higher in the neoplastic group compared to the bland group (PConclusions: The DECT quantitative parameters demonstrate significant potential as non-invasive markers for distinguishing between neoplastic and bland PVT.
- 1 June 2025
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 15 (6) , 5101-5113
Open AccessValue of dual-energy computed tomography quantitative parameters in differentiating neoplastic from bland portal vein thrombosis
Background: Portal vein thrombosis (PVT) is a common clinical pathological state involving distinct pathophysiological processes. Accurate discrimination of PVT nature is of utmost importance for guiding treatment strategies, but histopathology has limitations and imaging lacks quantitative indices. This study aimed to evaluate the feasibility and diagnostic value of quantitative parameters from dual-energy computed tomography (DECT), an advanced technique that allows for such quantitative evaluation, in distinguishing neoplastic from bland PVT. Methods: Computed tomography (CT) images of 173 patients with PVT (bland group, n=74; neoplastic group, n=99) were retrospectively analyzed. Portal venous phase iodine-based decomposition images were reconstructed to contrast iodine indices among groups, including thrombus iodine concentration (IC), normalized iodine concentration in the aorta (NIC-A), normalized iodine concentration in the portal vein (NIC-V), electron density (Rho), effective atomic number (Z), dual-energy index (DEI), and spectral slope (K). Diagnostic performance was evaluated using the area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and accuracy. Univariate and multivariate analyses selected DECT parameters and created a nomogram for prediction. Results: (I) The values of IC, NIC-A, NIC-V, Rho, Z, DEI, and K were significantly higher in the neoplastic group compared to the bland group (PConclusions: The DECT quantitative parameters demonstrate significant potential as non-invasive markers for distinguishing between neoplastic and bland PVT.
- 13 May 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 70 (3) , 399
Leriche Syndrome Presenting as Hypertensive Urgency
- 13 May 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 70 (3) , 399
Leriche Syndrome Presenting as Hypertensive Urgency
- Open Access
- 1 November 2024
- Published by Taylor & Francis in Journal of Hepatocellular Carcinoma
- Vol. ume 11, 2211-2222
Preoperative Noninvasive Prediction of Recurrence-Free Survival in Hepatocellular Carcinoma Using CT-Based Radiomics Model
Purpose: This study aims to explore the value of radiomics combined with clinical parameters in predicting recurrence-free survival (RFS) after the resection of hepatocellular carcinoma (HCC). Patients and Methods: In this retrospective study, a total of 322 patients with HCC who underwent contrast-enhanced computed tomography (CT) and radical surgical resection were enrolled and randomly divided into a training group (n = 223) and a validation group (n = 97). In the training group, Univariate and multivariate Cox regression analyses were employed to obtain clinical variables related to RFS for constructing the clinical model. The least absolute shrinkage and selection operator (LASSO) and multivariate Cox regression analyses were employed to construct the radiomics model, and the clinical-radiomics model was further constructed. Model prediction performance was subsequently assessed by the area under the time-dependent receiver operating characteristic curve (AUC) and calibration curve. Additionally, Kaplan-Meier analysis was used to evaluate the model’s value in predicting RFS. Correlations between radiomics features and pathological parameters were analyzed. Results: The clinical-radiomics model predicted RFS at 1, 2, and 3 years more accurately than the clinical or radiomics model alone (training group, AUC = 0.834, 0.765 and 0.831, respectively; validation group, AUC = 0.715, 0.710 and 0.793, respectively). The predicted high-risk subgroup based on the clinical-radiomics nomogram had shorter RFS than predicted low-risk subgroup in data sets, enabling risk stratification of various clinical subgroups. Correlation analysis revealed that the rad-score was positively related to microvascular invasion (MVI) and Edmondson-Steiner grade. Conclusion: The clinical-radiomics model effectively predicts RFS in HCC patients and identifies high-risk individuals for recurrence.
- 1 November 2024
- Published by Taylor & Francis in Journal of Hepatocellular Carcinoma
- Vol. ume 11, 2211-2222
Open AccessPreoperative Noninvasive Prediction of Recurrence-Free Survival in Hepatocellular Carcinoma Using CT-Based Radiomics Model
Purpose: This study aims to explore the value of radiomics combined with clinical parameters in predicting recurrence-free survival (RFS) after the resection of hepatocellular carcinoma (HCC). Patients and Methods: In this retrospective study, a total of 322 patients with HCC who underwent contrast-enhanced computed tomography (CT) and radical surgical resection were enrolled and randomly divided into a training group (n = 223) and a validation group (n = 97). In the training group, Univariate and multivariate Cox regression analyses were employed to obtain clinical variables related to RFS for constructing the clinical model. The least absolute shrinkage and selection operator (LASSO) and multivariate Cox regression analyses were employed to construct the radiomics model, and the clinical-radiomics model was further constructed. Model prediction performance was subsequently assessed by the area under the time-dependent receiver operating characteristic curve (AUC) and calibration curve. Additionally, Kaplan-Meier analysis was used to evaluate the model’s value in predicting RFS. Correlations between radiomics features and pathological parameters were analyzed. Results: The clinical-radiomics model predicted RFS at 1, 2, and 3 years more accurately than the clinical or radiomics model alone (training group, AUC = 0.834, 0.765 and 0.831, respectively; validation group, AUC = 0.715, 0.710 and 0.793, respectively). The predicted high-risk subgroup based on the clinical-radiomics nomogram had shorter RFS than predicted low-risk subgroup in data sets, enabling risk stratification of various clinical subgroups. Correlation analysis revealed that the rad-score was positively related to microvascular invasion (MVI) and Edmondson-Steiner grade. Conclusion: The clinical-radiomics model effectively predicts RFS in HCC patients and identifies high-risk individuals for recurrence.
- 20 August 2024
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 120 (4) , 697
Pancreatic Eurytremiasis Mimics Pancreatic Intraductal Papillary Mucinous Neoplasm
An abstract is unavailable. This article is available as a PDF only.
- 20 August 2024
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 120 (4) , 697
Pancreatic Eurytremiasis Mimics Pancreatic Intraductal Papillary Mucinous Neoplasm
An abstract is unavailable. This article is available as a PDF only.
- 29 April 2024
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 81 (8) , 884-885
Selenosis in a Woman With Systemic Lupus Erythematosus
This case report describes hypointensity in the cerebellum and midbrain in a 56-year-old woman with double vision and weakness and ptosis of eyelids.
- 29 April 2024
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 81 (8) , 884-885
Selenosis in a Woman With Systemic Lupus Erythematosus
This case report describes hypointensity in the cerebellum and midbrain in a 56-year-old woman with double vision and weakness and ptosis of eyelids.
- 4 March 2024
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 119 (7) , 1226
Esophageal Liposarcoma of the Oropharyngeal-Esophageal Junction
An abstract is unavailable. This article is available as a PDF only.
- 4 March 2024
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 119 (7) , 1226
Esophageal Liposarcoma of the Oropharyngeal-Esophageal Junction
An abstract is unavailable. This article is available as a PDF only.